Clinical Trial of Dipyridamole in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2011

Conditions
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Interventions
DRUG

Dipyridamole

Week 1- 50 mg bid Week 2- 50 mg am and 100 mg pm Weeks 3-6 100 mg am and 100 mg pm

OTHER

Olanzapine

Week 1- 5 mg BID Week 2- 5 mg am and 10 mg pm Weeks 3-6 10 mg am and 10 mg pm

Trial Locations (1)

21228

Maryland Psychiatric Research Center, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT00349973 - Clinical Trial of Dipyridamole in Schizophrenia | Biotech Hunter | Biotech Hunter